Myotonic Dystrophy Type 1:An Eyesight of Tri Repeat Expansion Disorder. Este artículo no está disponible.
Idioma: inglés
Editorial: Scholars' Press, 2017
- Tapa blanda
- Nuevo

Librería: Revaluation Books, Exeter, Reino UnidoRevaluation Books
Vendedor de 5 estrellas
Vendedor de IberLibro desde 6 de enero de 2003
No disponible
Tapa blanda
Condición: Nuevo
EUR 98,09
Descripción del artículo del vendedor
80 pages. 8.66x5.91x0.19 inches. In Stock.
N° de ref. del artículo __3330651776
- Título
- Myotonic Dystrophy Type 1:An Eyesight of Tri Repeat Expansion Disorder
- Autor
- Kumar, Ashok/ Agarwal, Sarita
- Editorial
- Scholars' Press
- Año de publicación
- 2017
- Estado
- Brand New
- Encuadernación
- Paperback
- Idioma
- inglés
- ISBN 10
- 3330651776
- ISBN 13
- 9783330651777
- Peso del artículo
- 0,17 kilogramos
Myotonic dystrophy is an autosomal dominant, multisystem disorder that is characterized by myotonic myopathy. The symptoms and severity of myotonic dystrophy type l (DM1) ranges from severe and congenital forms, which frequently result in death because of respiratory deficiency, through to late-onset baldness and cataract. In adult patients, cardiac conduction abnormalities may occur and cause a shorter life span. In subsequent generations, the symptoms in DM1 may present at an earlier age and have a more severe course (anticipation). PCR based screening is reliable and should be used as an initial screening test for DM diagnosis and the positive results should then be confirmed by Southern Blotting. It is appropriate to offer genetic counseling to young adults who affected or are at risk. A series of promising and effective antisense oligonucleotides and small molecules are in the pipeline of development but much work still needs to be done. Much progress has been made, additional basic and translational studies will be required to understand molecular pathogenesis of DM1 and to develop safe and effective treatment strategies.
“Sinopsis” puede pertenecer a otra edición de este título.
Reseña del editor
Myotonic dystrophy is an autosomal dominant, multisystem disorder that is characterized by myotonic myopathy. The symptoms and severity of myotonic dystrophy type l (DM1) ranges from severe and congenital forms, which frequently result in death because of respiratory deficiency, through to late-onset baldness and cataract. In adult patients, cardiac conduction abnormalities may occur and cause a shorter life span. In subsequent generations, the symptoms in DM1 may present at an earlier age and have a more severe course (anticipation). PCR based screening is reliable and should be used as an initial screening test for DM diagnosis and the positive results should then be confirmed by Southern Blotting. It is appropriate to offer genetic counseling to young adults who affected or are at risk. A series of promising and effective antisense oligonucleotides and small molecules are in the pipeline of development but much work still needs to be done. Much progress has been made, additional basic and translational studies will be required to understand molecular pathogenesis of DM1 and to develop safe and effective treatment strategies.
“Acerca de” puede pertenecer a otra edición de este título.